Platelet rich plasma and fresh frozen bone allograft as enhancement of implant fixation. An experimental study in dogs.
Platelet rich plasma (PRP) is an autologous source of growth factors. By application of PRP around cementless implants alone or in combination with bone allograft chips, early implant fixation and gap healing could be improved. We inserted two porous HA coated titanium implants extraarticularly in each proximal humerus of eight dogs. Each implant was surrounded by a 2.5 mm gap. Four treatments were block randomized to the four gaps in each dog: Treatment 1: empty gap, treatment 2: PRP, treatment 3: fresh frozen bone allograft, treatment 4: fresh frozen bone allograft+PRP. PRP was prepared from each dog prior to operation by isolating the buffycoat from centrifuged blood samples. Platelet count in PRP was increased 670% compared to baseline level. Calcium/thrombin was added to degranulate platelets and form a gel. Three weeks after surgery, push-out test and histomorphometri was performed. After three weeks, the non-allografted implants had poor mechanical properties. Bone grafting significantly increased implant fixation, bone formation in the gap and bone growth on the implant surface. We found no significant effect of PRP alone or mixed with bone allograft on implant fixation or bone formation. In conclusion, we showed the importance of bone allografting on early implant fixation and bone incorporation but we found no effect of PRP. More studies are needed to investigate the effect and possible clinical applications of platelet concentrates which are now being commercialised.
Jensen
T B
TB
Orthopaedic Research Group, Institute of Experimental Clinical Research, Aarhus University Hospital, Aarhus Kommunehospital, 8000 Aarhus C, Denmark. tbj@webspeed.dk
Rahbek
O
O
Overgaard
S
S
Søballe
K
K
D000818:Animals; D001696:Biomechanical Phenomena; D001792:Blood Platelets / Q000502:physiology*; D016025:Bone Transplantation; D020099:Coated Materials, Biocompatible / Q000494:pharmacology; D004285:Dogs; D006882:Hydroxyapatites / Q000494:pharmacology; D020007:Implants, Experimental; D010012:Osteogenesis; D014184:Transplantation, Homologous
D020099:Coated Materials, Biocompatible; D006882:Hydroxyapatites